This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Randomized Controlled Trial

Larry C. Clark, MPH, PhD; Gerald F. Combs, Jr, PhD; Bruce W. Turnbull, PhD; Elizabeth H. Slate, PhD; Dan K. Chalker, MD; James Chow, MD; Loretta S. Davis, MD; Renee A. Glover, MD; Gloria F. Graham, MD; Earl G. Gross, MD; Arnon Krongrad, MD; Jack L. Lesher, Jr, MD; H. Kim Park, MD; Beverly B. Sanders, Jr, MD; Cameron L. Smith, MD; J. Richard Taylor, MD

JAMA. 1996;276(24):1957-1963.

Abstract
Objective.
—To determine whether a nutritional supplement of selenium will decrease the incidence of cancer.

Design.
—A multicenter, double-blind, randomized, placebo-controlled cancer prevention trial.

Setting.
—Seven dermatology clinics in the eastern United States.

Patients.
—A total of 1312 patients (mean age, 63 years; range, 18-80 years) with a history of basal cell or squamous cell carcinomas of the skin were randomized from 1983 through 1991. Patients were treated for a mean (SD) of 4.5 (2.8) years and had a total follow-up of 6.4 (2.0) years.

Interventions.
—Oral administration of 200 µg of selenium per day or placebo.

Main Outcome Measures.
—The primary end points for the trial were the incidences of basal and squamous cell carcinomas of the skin. The secondary end points, established in 1990, were all-cause mortality and total cancer mortality, total cancer incidence, and the incidences of lung, prostate, and colorectal cancers.

Results.
—After a total follow-up of 8271 person-years, selenium treatment did not significantly affect the incidence of basal cell or squamous cell skin cancer. There were 377 new cases of basal cell skin cancer among patients in the selenium group and 350 cases among the control group (relative risk [RR], 1.10; 95% confidence interval [CI], 0.95-1.28), and 218 new squamous cell skin cancers in the selenium group and 190 cases among the controls (RR, 1.14; 95% CI, 0.93-1.39). Analysis of secondary end points revealed that, compared with controls, patients treated with selenium had a nonsignificant reduction in all-cause mortality (108 deaths in the selenium group and 129 deaths in the control group [RR, 0.83; 95% CI, 0.63-1.08]) and significant reductions in total cancer mortality (29 deaths in the selenium treatment group and 57 deaths in controls [RR, 0.50; 95% CI, 0.31-0.80]), total cancer incidence (77 cancers in the selenium group and 119 in controls [RR, 0.63; 95% CI, 0.47-0.85]), and incidences of lung, colorectal, and prostate cancers. Primarily because of the apparent reductions in total cancer mortality and total cancer incidence in the selenium group, the blinded phase of the trial was stopped early. No cases of selenium toxicity occurred.

Conclusions.
—Selenium treatment did not protect against development of basal or squamous cell carcinomas of the skin. However, results from secondary end-point analyses support the hypothesis that supplemental selenium may reduce the incidence of, and mortality from, carcinomas of several sites. These effects of selenium require confirmation in an independent trial of appropriate design before new public health recommendations regarding selenium supplementation can be made.

Author Affiliations
for the Nutritional Prevention of Cancer Study Group

Footnotes
Affiliations for the named authors and a complete list of the Nutritional Prevention of Cancer Study Group appear at the end of this article.

Corresponding author: Larry C. Clark, MPH, PhD, Arizona Cancer Center, 2504 E Elm St, Tucson, AZ 85716-3417 (e-mail: selenium@ccit-arizona.edu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman and Hawk
Cancer Res. 2009;69:5269-5284.
ABSTRACT | FULL TEXT  

Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults
Combs et al.
Am. J. Clin. Nutr. 2009;89:1808-1814.
ABSTRACT | FULL TEXT  

Cancer Prevention Research: Back to the Future
Lippman
Cancer Prevention Research 2009;2:503-513.
FULL TEXT  

Antioxidant Supplementation and Cancer Prevention
Bosland and McCormick
JAMA 2009;301:1877-1878.
FULL TEXT  

A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model
Venkateswaran et al.
Cancer Prevention Research 2009;2:473-483.
ABSTRACT | FULL TEXT  

Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit
Wang et al.
Cancer Prevention Research 2009;2:484-495.
ABSTRACT | FULL TEXT  

Serum Antioxidants and Skin Cancer Risk: An 8-Year Community-Based Follow-up Study
van der Pols et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1167-1173.
ABSTRACT | FULL TEXT  

Cellular proliferation and vascularization in ovine fetal ovaries: effects of undernutrition and selenium in maternal diet
Grazul-Bilska et al.
Reproduction 2009;137:699-707.
ABSTRACT | FULL TEXT  

Landmarks in the History of Cancer Epidemiology
Greenwald and Dunn
Cancer Res. 2009;69:2151-2162.
ABSTRACT | FULL TEXT  

Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer
Tsavachidou et al.
JNCI J Natl Cancer Inst 2009;101:306-320.
ABSTRACT | FULL TEXT  

Selenium and Vitamin E: Interesting Biology and Dashed Hope
Klein
JNCI J Natl Cancer Inst 2009;101:283-285.
FULL TEXT  

In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes
Jiang et al.
Molecular Cancer Therapeutics 2009;8:682-691.
ABSTRACT | FULL TEXT  

The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) Reveals the Need for Better Understanding of Selenium Biology
Hatfield and Gladyshev
Mol. Interv. 2009;9:18-21.
ABSTRACT | FULL TEXT  

Transcript Analysis of the Selenoproteome Indicates That Dietary Selenium Requirements of Rats Based on Selenium-Regulated Selenoprotein mRNA Levels Are Uniformly Less Than Those Based on Glutathione Peroxidase Activity
Barnes et al.
J. Nutr. 2009;139:199-206.
ABSTRACT | FULL TEXT  

Vitamin Supplements and Cancer Prevention: Where Do Randomized Controlled Trials Stand?
Albanes
JNCI J Natl Cancer Inst 2009;101:2-4.
FULL TEXT  

Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial
Gaziano et al.
JAMA 2009;301:52-62.
ABSTRACT | FULL TEXT  

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Lippman et al.
JAMA 2009;301:39-51.
ABSTRACT | FULL TEXT  

Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial
Lin et al.
JNCI J Natl Cancer Inst 2009;101:14-23.
ABSTRACT | FULL TEXT  

Randomized Trials of Antioxidant Supplementation for Cancer Prevention: First Bias, Now Chance--Next, Cause
Gann
JAMA 2009;301:102-103.
FULL TEXT  

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk
Cooper et al.
Cancer Res. 2008;68:10171-10177.
ABSTRACT | FULL TEXT  

Locally Generated Methylseleninic Acid Induces Specific Inactivation of Protein Kinase C Isoenzymes: RELEVANCE TO SELENIUM-INDUCED APOPTOSIS IN PROSTATE CANCER CELLS
Gundimeda et al.
J. Biol. Chem. 2008;283:34519-34531.
ABSTRACT | FULL TEXT  

Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Allen et al.
Am. J. Clin. Nutr. 2008;88:1567-1575.
ABSTRACT | FULL TEXT  

Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice
Banning et al.
Cancer Res. 2008;68:9746-9753.
ABSTRACT | FULL TEXT  

Genome-wide screen of Saccharomyces cerevisiae null allele strains identifies genes involved in selenomethionine resistance
Bockhorn et al.
Proc. Natl. Acad. Sci. USA 2008;105:17682-17687.
ABSTRACT | FULL TEXT  

Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells
Xiang et al.
Carcinogenesis 2008;29:2175-2181.
ABSTRACT | FULL TEXT  

Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells
Li et al.
Molecular Cancer Therapeutics 2008;7:3056-3063.
ABSTRACT | FULL TEXT  

Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue
Zhang and Zarbl
Cancer Prevention Research 2008;1:119-127.
ABSTRACT | FULL TEXT  

Suppression of Colorectal Oncogenesis by Selenium-Enriched Milk Proteins: Apoptosis and K-ras Mutations
Hu et al.
Cancer Res. 2008;68:4936-4944.
ABSTRACT | FULL TEXT  

Tumor Vascular Maturation and Improved Drug Delivery Induced by Methylselenocysteine Leads to Therapeutic Synergy with Anticancer Drugs
Bhattacharya et al.
Clin. Cancer Res. 2008;14:3926-3932.
ABSTRACT | FULL TEXT  

Variation in the Selenoenzyme Genes and Risk of Advanced Distal Colorectal Adenoma
Peters et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1144-1154.
ABSTRACT | FULL TEXT  

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
Li et al.
Carcinogenesis 2008;29:1005-1012.
ABSTRACT | FULL TEXT  

Interaction of Glutathione and Sodium Selenite In vitro Investigated by Electrospray Ionization Tandem Mass Spectrometry
Cui et al.
J Biochem 2008;143:685-693.
ABSTRACT | FULL TEXT  

The Role of Selenium in Chronic Disease
Boosalis
Nutr Clin Pract 2008;23:152-160.
ABSTRACT | FULL TEXT  

Effects of level and source of dietary selenium on maternal and fetal body weight, visceral organ mass, cellularity estimates, and jejunal vascularity in pregnant ewe lambs
Neville et al.
J ANIM SCI 2008;86:890-901.
ABSTRACT | FULL TEXT  

Effect of Dietary Selenium on the Promotion of Hepatocarcinogenesis by 3,3', 4,4'-Tetrachlorobiphenyl and 2,2', 4,4', 5,5'-Hexachlorobiphenyl
Stemm et al.
Exp. Biol. Med. 2008;233:366-376.
ABSTRACT | FULL TEXT  

A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium
Adams
Bioscience Horizons 2008;1:75-84.
ABSTRACT | FULL TEXT  

Serum Selenium Levels and All-Cause, Cancer, and Cardiovascular Mortality Among US Adults
Bleys et al.
Arch Intern Med 2008;168:404-410.
ABSTRACT | FULL TEXT  

Kruppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition
Liu et al.
Mol Cancer Res 2008;6:306-313.
ABSTRACT | FULL TEXT  

Animal Models in Nutrition Research
Baker
J. Nutr. 2008;138:391-396.
ABSTRACT | FULL TEXT  

Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis
Bardia et al.
Mayo Clin Proc. 2008;83:23-34.
ABSTRACT | FULL TEXT  

Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-{alpha} p53+/ mice
Aichler et al.
Carcinogenesis 2007;28:2002-2007.
ABSTRACT | FULL TEXT  

Antioxidant Supplementation Increases the Risk of Skin Cancers in Women but Not in Men
Hercberg et al.
J. Nutr. 2007;137:2098-2105.
ABSTRACT | FULL TEXT  

Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial
Stranges et al.
ANN INTERN MED 2007;147:217-223.
ABSTRACT | FULL TEXT  

Racial Differences in Serum Selenium Concentration: Analysis of US Population Data from the Third National Health and Nutrition Examination Survey
Vogt et al.
Am J Epidemiol 2007;166:280-288.
ABSTRACT | FULL TEXT  

Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-{kappa}B activation
Park et al.
Carcinogenesis 2007;28:837-847.
ABSTRACT | FULL TEXT  

Extracellular Production of Hydrogen Selenide Accounts for Thiol-assisted Toxicity of Selenite against Saccharomyces cerevisiae
Tarze et al.
J. Biol. Chem. 2007;282:8759-8767.
ABSTRACT | FULL TEXT  

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Bjelakovic et al.
JAMA 2007;297:842-857.
ABSTRACT | FULL TEXT  

Suppression of Human Immunodeficiency Virus Type 1 Viral Load With Selenium Supplementation: A Randomized Controlled Trial
Hurwitz et al.
Arch Intern Med 2007;167:148-154.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the Science Panel
Am. J. Clin. Nutr. 2007;85:257S-264S.
FULL TEXT  

Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements
Prentice
Am. J. Clin. Nutr. 2007;85:308S-313S.
ABSTRACT | FULL TEXT  

The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships
Mathers and Hesketh
J. Nutr. 2007;137:253S-258S.
ABSTRACT | FULL TEXT  

Poster Abstracts
J. Nutr. 2007;137:278S-295S.
FULL TEXT  

Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells
Zhao et al.
Molecular Cancer Therapeutics 2006;5:3275-3284.
ABSTRACT | FULL TEXT  

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices
Doyle et al.
CA Cancer J Clin 2006;56:323-353.
ABSTRACT | FULL TEXT  

Chemoprevention of Second Cancers
Mayne and Cartmel
Cancer Epidemiol. Biomarkers Prev. 2006;15:2033-2037.
ABSTRACT | FULL TEXT  

Selenium and coronary heart disease: a meta-analysis.
Flores-Mateo et al.
Am. J. Clin. Nutr. 2006;84:762-773.
ABSTRACT | FULL TEXT  

Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake
Fowke et al.
Carcinogenesis 2006;27:2096-2102.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the-Science Panel*
ANN INTERN MED 2006;145:364-371.
FULL TEXT  

Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Malewicz et al.
Carcinogenesis 2006;27:1739-1747.
ABSTRACT | FULL TEXT  

Micronutrients in health and disease.
Shenkin
Postgrad. Med. J. 2006;82:559-567.
ABSTRACT | FULL TEXT  

Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia.
Marshall et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1479-1484.
ABSTRACT | FULL TEXT  

Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck et al.
Molecular Cancer Therapeutics 2006;5:2078-2085.
ABSTRACT | FULL TEXT  

(Nutritional) chemoprevention of cancer: what's up?
Baron
JNCI J Natl Cancer Inst 2006;98:945-946.
FULL TEXT  

Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review.
Davies et al.
JNCI J Natl Cancer Inst 2006;98:961-973.
ABSTRACT | FULL TEXT  

Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Hu et al.
Molecular Cancer Therapeutics 2006;5:1873-1882.
ABSTRACT | FULL TEXT  

Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer
El-Bayoumy et al.
Carcinogenesis 2006;27:1369-1376.
ABSTRACT | FULL TEXT  

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Kelloff et al.
Clin. Cancer Res. 2006;12:3661-3697.
ABSTRACT | FULL TEXT  

Toward a Core Nutraceutical Program for Cancer Management
McCarty and Block
Integr Cancer Ther 2006;5:150-171.
ABSTRACT  

The Selenium Metabolite Methylselenol Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells
Zeng et al.
J. Nutr. 2006;136:1528-1532.
ABSTRACT | FULL TEXT  

Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model
Diwadkar-Navsariwala et al.
Proc. Natl. Acad. Sci. USA 2006;103:8179-8184.
ABSTRACT | FULL TEXT  

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours
Last et al.
Ann Oncol 2006;17:773-779.
ABSTRACT | FULL TEXT  

Both Selenoproteins and Low Molecular Weight Selenocompounds Reduce Colon Cancer Risk in Mice with Genetically Impaired Selenoprotein Expression
Irons et al.
J. Nutr. 2006;136:1311-1317.
ABSTRACT | FULL TEXT  

Effects of Selenium Supplementation on Cardiovascular Disease Incidence and Mortality: Secondary Analyses in a Randomized Clinical Trial
Stranges et al.
Am J Epidemiol 2006;163:694-699.
ABSTRACT | FULL TEXT  

Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial.
Burk et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:804-810.
ABSTRACT | FULL TEXT  

Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer.
Chun et al.
Molecular Cancer Therapeutics 2006;5:913-918.
ABSTRACT | FULL TEXT  

Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Sabichi et al.
Clin. Cancer Res. 2006;12:2178-2184.
ABSTRACT | FULL TEXT  

Selenium, apoptosis, and colorectal adenomas.
Connelly-Frost et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:486-493.
ABSTRACT | FULL TEXT  

Cancer Chemoprevention by Garlic and Garlic-Containing Sulfur and Selenium Compounds
El-Bayoumy et al.
J. Nutr. 2006;136:864S-869S.
ABSTRACT | FULL TEXT  

Hydroponic Cultivation Offers A Practical Means of Producing Selenium-Enriched Garlic
Tsuneyoshi et al.
J. Nutr. 2006;136:870S-872S.
ABSTRACT | FULL TEXT  

Expression of p53 Enhances Selenite-Induced Superoxide Production and Apoptosis in Human Prostate Cancer Cells
Zhao et al.
Cancer Res. 2006;66:2296-2304.
ABSTRACT | FULL TEXT  

A Phase I and Pharmacokinetic Study of Fixed-Dose Selenomethionine and Irinotecan in Solid Tumors
Fakih et al.
Clin. Cancer Res. 2006;12:1237-1244.
ABSTRACT | FULL TEXT  

NMR Structures of the Selenoproteins Sep15 and SelM Reveal Redox Activity of a New Thioredoxin-like Family
Ferguson et al.
J. Biol. Chem. 2006;281:3536-3543.
ABSTRACT | FULL TEXT  

Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma.
Cai et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:294-300.
ABSTRACT | FULL TEXT  

High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Peters et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:315-320.
ABSTRACT | FULL TEXT  

Toxicology of Micronutrients: Adverse Effects and Uncertainty
Renwick
J. Nutr. 2006;136:493S-501S.
ABSTRACT | FULL TEXT  

Selenium, the Thyroid, and the Endocrine System
Kohrle et al.
Endocr. Rev. 2005;26:944-984.
ABSTRACT | FULL TEXT  

Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer
Hu et al.
J. Nutr. 2005;135:3021S-3024S.
ABSTRACT | FULL TEXT  

A Novel Cysteine-rich Domain of Sep15 Mediates the Interaction with UDP-glucose:Glycoprotein Glucosyltransferase
Labunskyy et al.
J. Biol. Chem. 2005;280:37839-37845.
ABSTRACT | FULL TEXT  

Additional Information
JAMA 2005;294:E1-E3.
FULL TEXT